CEO Corner: Curing Cancer Is Millennium's Vision

(NECN) - Millennium: The Takeda Oncology Company has a clear and bold vision: to cure cancer.

CEO Anna Protopapas shares some of the dramatic advances in cancer care.

How are Millennium's scientists working to eradicate various forms of this disease?

"We've been able to use the information we have, as a part of the 20 years of research we've done, to really design drugs that can kill those cancer cells and prevent their growth," said Protopapas.

Protopapas also discusses some of the projects are in the pipeline.

See the attached video for the complete discussion.

Contact Us